07:00 , Jun 7, 2010 |  BC Week In Review  |  Clinical News

Marinomed preclinical data

In mouse models of early- and late-stage allergic reactions, MAM-06.301 dose-dependently inhibited allergic airway inflammation. MAM-06.301 is an anti-inflammatory compound derived from Aesculus hippocastanum seed extracts. Data were published in BMC Immunology. Marinomed Biotechnologie GmbH,...